Pages that link to "Q37479405"

The following pages link to Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice (Q37479405):

Displaying 24 items.

• An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels (Q26751302) (← links)
• PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease (Q28069549) (← links)
• Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs (Q33959032) (← links)
• Nuclear receptors in neurodegenerative diseases. (Q34580020) (← links)
• Insulin resistance in Alzheimer's disease (Q34622157) (← links)
• Impaired firing properties of dentate granule neurons in an Alzheimer's disease animal model are rescued by PPARγ agonism. (Q35178508) (← links)
• Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy (Q35867310) (← links)
• Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease. (Q37644290) (← links)
• Role of PPAR γ in the Differentiation and Function of Neurons (Q38253356) (← links)
• Epigallocatechin Gallate Attenuates β-Amyloid Generation and Oxidative Stress Involvement of PPARγ in N2a/APP695 Cells (Q38728733) (← links)
• PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease. (Q38776236) (← links)
• MicroRNA-34c Downregulation Ameliorates Amyloid-β-Induced Synaptic Failure and Memory Deficits by Targeting VAMP2. (Q38832895) (← links)
• Therapeutic potential of nuclear receptor agonists in Alzheimer's disease (Q39164346) (← links)
• Age-related synaptic dysfunction in Tg2576 mice starts as a failure in early long-term potentiation which develops into a full abolishment of late long-term potentiation (Q40249967) (← links)
• Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia. (Q41501850) (← links)
• Diminished dentate gyrus filtering of cortical input leads to enhanced area CA3 excitability after mild traumatic brain injury (Q47862063) (← links)
• Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone (Q48321494) (← links)
• PPARγ agonism attenuates cocaine cue reactivity (Q48930376) (← links)
• Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms. (Q52343842) (← links)
• Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: An update (Q56999967) (← links)
• Transferrin is responsible for mediating the effects of iron ions on the regulation of anterior pharynx-defective-1α/β and Presenilin 1 expression via PGE and PGD at the early stage of Alzheimer's Disease (Q58077633) (← links)
• Divergent Mechanisms for PPARγ Agonism in Ameliorating Aging-Related Versus Cranial Irradiation-Induced Context Discrimination Deficits (Q64092789) (← links)
• Rosiglitazone rescues human neural stem cells from amyloid-beta induced ER stress via PPARγ dependent signaling (Q89379684) (← links)
• Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits (Q92510690) (← links)